| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.7M | +103.5% |
| Cost of Revenue | $7.6M | +60.2% |
| Gross Profit | $4.1M | +306.0% |
| R&D Expense | $53K | -82.8% |
| SG&A Expense | $11.3M | +241.2% |
| Operating Income | -$7.3M | -120.3% |
| Pre-tax Income | -$7.5M | -126.6% |
| Income Tax | -$92K | -237.3% |
| Net Income | -$7.4M | -119.4% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $986K | +323.3% |
| Inventory | $1.6M | +953.3% |
| Current Assets | $12.8M | +3.8% |
| Total Assets | $38.5M | +193.7% |
| Current Liabilities | $4.5M | +65.1% |
| Long-term Debt | $158K | +0.0% |
| Total Liabilities | $5.9M | +74.2% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | -964.8% |
| Investing Cash Flow | -$14.6M | -6573.0% |
| Financing Cash Flow | $18.6M | +60.3% |
| Stockholders' Equity |
| $32.7M |
| +234.9% |